Dimerix Bioscience Pty Limited
- Address
- 425 Smith Street
Sponsor Overview
Specializations
Kidney Disease
Dimerix Bioscience Pty Limited focuses on focal segmental glomerulosclerosis, a severe form of glomerular disease associated with progressive loss of kidney function.
- Focal segmental glomerulosclerosis
- Proteinuria
- Estimated glomerular filtration rate
The sponsor’s active clinical work is centred on adult patients with persistent renal impairment and the preservation of kidney function in a nephrology setting.
Nephrology Outcomes
Its research interest includes clinical endpoints used in renal medicine, particularly measures of urinary protein loss and long-term changes in eGFR.
- Urine protein-to-creatinine ratio
- Renal function decline
- Chronic kidney disease
This places emphasis on disease monitoring and functional kidney outcomes in patients with progressive proteinuric kidney disorders.
Renin-Angiotensin System–Related Care
The sponsor’s clinical activity also involves patients receiving an angiotensin receptor blocker, reflecting interest in treatments used to support blood pressure control and reduce glomerular stress.
- Angiotensin receptor blockers
- Supportive renal therapy
- Proteinuria management
Its therapeutic landscape sits within adjunctive care for glomerular pathology and the management of persistent urinary protein loss.
Long-Term Safety and Tolerability
Dimerix Bioscience Pty Limited includes ongoing evaluation of long-term safety and tolerability in patients with FSGS, with attention to sustained treatment use in a chronic kidney condition.
- Chronic treatment monitoring
- Adult nephrology
- Persistent renal disease
The clinical focus remains on adult populations with progressive renal disease requiring extended observation of kidney-related outcomes.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Efficacy and Safety Evaluation of DMX-200 in Adult Patients with Focal Segmental Glomerulosclerosis Receiving Angiotensin II Receptor Blocker Therapy |  Czechia Denmark France Germany Italy Portugal Spain | Not Recruiting |
Data & Insights
This sponsor works with 8 molecules, of which 1 is not being studied by other sponsors.
This sponsor has worked with 37 sites across their trial portfolio.
Therapeutic Focus
- 1.Immune System Diseases1 trial322 other sponsors
Partnered Research Centres
37 centres- Address
- 264 Rue Saint Pierre, 13005 Marseille
- Address
- Num Voie 47 A 83, 47 Boulevard De L Hopital, 75013 Paris
- Address
- Piazzale Giulio Cesare 11, 70124 Bari
- Address
- Via Pietro Albertoni 15, 40138 Bologna
- Address
- Lugar De Sete Fontes S Victor, 4710-243 Braga
- Address
- Langenbeckstrasse 1, Oberstadt, 55131 Mainz
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Dimerix Bioscience Pty Limited.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.